NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/29/2024
Back to search
Official data from USPTO
CANCER DIAGNOSTICS INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANCER DIAGNOSTICS INSTITUTE
ST13
US500000085810949Class
42, 44
Filing
85810949
Registration
4399135
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
02/29/2024
Trademark type
Word
Nice classes
42, 44
Filing date
12/27/2012
Registration date
09/10/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/29/2024
Last transaction
02/29/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2005-00-00
First use in commerce
2005-00-00
Drawing code
4
Owner type
03
Owner location
Plainview, NY, US
Examiner
PARK, JENNY K
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Acupath Laboratories, Inc.
Representatives
Daniel Jacob Gross MYERS WOLIN, LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of cancer; providing clinical scientific testing services and medical research and scientific testing in the field of human disease and human medical conditions
Class 44
medical testing for diagnostic or treatment purposes; cancer screening services; medical testing of tissue samples for diagnostic or treatment purposes; medical testing services using hybridization probes for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/29/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/29/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/29/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/08/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/10/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/04/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/04/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/04/2019
E815
TEAS SECTION 8 & 15 RECEIVED
12/04/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/10/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2013
PUBO
PUBLISHED FOR OPPOSITION
06/25/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/22/2013
ALIE
ASSIGNED TO LIE
05/21/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
05/13/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/13/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
05/13/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/13/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2013
GNRT
NON-FINAL ACTION E-MAILED
04/22/2013
CNRT
NON-FINAL ACTION WRITTEN
04/22/2013
DOCK
ASSIGNED TO EXAMINER
04/12/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2013
NWAP
NEW APPLICATION ENTERED
12/31/2012
Continuous trademark protection
Get notified about every new filing that threatens CANCER DIAGNOSTICS INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.